TrialArteriosclerosis, thrombosis, and vascular biology2025

Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study.

Pietro Minuz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.